Literature DB >> 24753754

RNAi targeting GPR4 influences HMEC-1 gene expression by microarray analysis.

Juan Ren1, Yuelang Zhang2, Hui Cai3, Hongbing Ma4, Dongli Zhao1, Xiaozhi Zhang1, Zongfang Li4, Shufeng Wang1, Jiangsheng Wang1, Rui Liu1, Yi Li1, Jiansheng Qian1, Hongxia Wei1, Liying Niu1, Yan Liu1, Lisha Xiao3, Muyang Ding3, Shiwen Jiang5.   

Abstract

G-protein coupled receptor 4 (GPR4) belongs to a protein family comprised of 3 closely related G protein-coupled receptors. Recent studies have shown that GPR4 plays important roles in angiogenesis, proton sensing, and regulating tumor cells as an oncogenic gene. How GPR4 conducts its functions? Rare has been known. In order to detect the genes related to GPR4, microarray technology was employed. GPR4 is highly expressed in human vascular endothelial cell HMEC-1. Small interfering RNA against GPR4 was used to knockdown GPR4 expression in HMEC-1. Then RNA from the GPR4 knockdown cells and control cells were analyzed through genome microarray. Microarray results shown that among the whole genes and expressed sequence tags, 447 differentially expressed genes were identified, containing 318 up-regulated genes and 129 down-regulated genes. These genes whose expression dramatically changed may be involved in the GPR4 functions. These genes were related to cell apoptosis, cytoskeleton and signal transduction, cell proliferation, differentiation and cell-cycle regulation, gene transcription and translation and cell material and energy metabolism.

Entities:  

Keywords:  GPR4; RNAi; microarray

Year:  2014        PMID: 24753754      PMCID: PMC3992399     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Relations between GPR4 expression, microvascular density (MVD) and clinical pathological characteristics of patients with epithelial ovarian carcinoma (EOC).

Authors:  Juan Ren; Wen Jin; Yan-E Gao; Yuelang Zhang; Xiaozhi Zhang; Dongli Zhao; Hongbing Ma; Zongfang Li; Jiansheng Wang; Lisha Xiao; Rui Liu; Yuanyuan Chen; Jiansheng Qian; Liying Niu; Hongxia Wei; Yan Liu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

2.  Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.

Authors:  Masayuki Tobo; Hideaki Tomura; Chihiro Mogi; Ju-Qiang Wang; Jin-Peng Liu; Mayumi Komachi; Alatangaole Damirin; Takao Kimura; Naoya Murata; Hitoshi Kurose; Koichi Sato; Fumikazu Okajima
Journal:  Cell Signal       Date:  2007-03-30       Impact factor: 4.315

3.  Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor.

Authors:  Li V Yang; Caius G Radu; Meenakshi Roy; Sunyoung Lee; Jami McLaughlin; Michael A Teitell; M Luisa Iruela-Arispe; Owen N Witte
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

4.  Cloning, sequencing and tissue distribution of two related G protein-coupled receptor candidates expressed prominently in human lung tissue.

Authors:  S An; C Tsai; E J Goetzl
Journal:  FEBS Lett       Date:  1995-11-13       Impact factor: 4.124

5.  Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor.

Authors:  Lorenza Wyder; Thomas Suply; Bérangère Ricoux; Eric Billy; Christian Schnell; Birgit U Baumgarten; Sauveur Michel Maira; Claudia Koelbing; Mireille Ferretti; Bernd Kinzel; Matthias Müller; Klaus Seuwen; Marie-Gabrielle Ludwig
Journal:  Angiogenesis       Date:  2011-11-02       Impact factor: 9.596

Review 6.  Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.

Authors:  Julie Dwyer; He Li; Dakang Xu; Jun-Ping Liu
Journal:  Ann N Y Acad Sci       Date:  2007-10       Impact factor: 5.691

Review 7.  Applications of RNA interference in mammalian systems.

Authors:  Scott E Martin; Natasha J Caplen
Journal:  Annu Rev Genomics Hum Genet       Date:  2007       Impact factor: 8.929

8.  Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

Authors:  Swneke D Bailey; Changchun Xie; Ron Do; Alexandre Montpetit; Rafael Diaz; Viswanathan Mohan; Bernard Keavney; Salim Yusuf; Hertzel C Gerstein; James C Engert; Sonia Anand
Journal:  Diabetes Care       Date:  2010-07-13       Impact factor: 19.112

9.  In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.

Authors:  Naotaka Hashiya; Nobuo Jo; Motokuni Aoki; Kunio Matsumoto; Toshikazu Nakamura; Yasufumi Sato; Nahoko Ogata; Toshio Ogihara; Yasufumi Kaneda; Ryuichi Morishita
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

Review 10.  Current prospects for RNA interference-based therapies.

Authors:  Beverly L Davidson; Paul B McCray
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

View more
  2 in total

1.  ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.

Authors:  Weiran Gao; Xifan Mei; Jikun Wang; Xianglin Zhang; Yajiang Yuan
Journal:  Tumour Biol       Date:  2015-04-20

2.  The downregulation of OPN inhibits proliferation and migration and regulate activation of Erk1/2 in ECA-109 cells.

Authors:  Song-Tao Xu; Fa-Zhang Zou; Li-Na Cai; Wan-Ling Xu
Journal:  Int J Clin Exp Med       Date:  2015-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.